Drug profile · INN
glyceryl trinitrate
TRANSIDERM-NITRO 25
glyceryl trinitrate (TRANSIDERM-NITRO 25) is a soluble guanylate cyclase activator. Associated with Sanofi-aventis Healthcare Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — glyceryl trinitrate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.81
Quick answer
glyceryl trinitrate (TRANSIDERM-NITRO 25) is a soluble guanylate cyclase activator. Associated with Sanofi-aventis Healthcare Pty Ltd.
Key facts
INN glyceryl trinitrate
Brand TRANSIDERM-NITRO 25
Mechanism Soluble guanylate cyclase activator
Target Soluble guanylate cyclase
Originator Sanofi-aventis Healthcare Pty Ltd
Mechanism of action
Soluble guanylate cyclase activator
Primary target: Soluble guanylate cyclase
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is glyceryl trinitrate?
glyceryl trinitrate (TRANSIDERM-NITRO 25) is a soluble guanylate cyclase activator. Associated with Sanofi-aventis Healthcare Pty Ltd.
What is the brand name for glyceryl trinitrate?
TRANSIDERM-NITRO 25 is a marketed brand name for glyceryl trinitrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.